Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
ViroLogic and ACLARA Announce Stockholder Approval of Merger Merger Expected to Be Completed By End of Day SOUTH SAN FRANCISCO, Calif. and...
Iceland Genomics Corporation and ACLARA Collaborating on Cancer Biomarkers REYKJAVIK, Iceland, Dec. 2 /PRNewswire/ -- Iceland Genomics...
ACLARA Announces Third Quarter 2004 Financial Results MOUNTAIN VIEW, Calif. Nov. 9 /PRNewswire-FirstCall/ -- ACLARA BioSciences (NASDAQ:ACLA...
ViroLogic and ACLARA to Mail Revised Definitive Proxy for Proposed Merger New Date Set for Stockholder Meetings SOUTH SAN FRANCISCO, Calif. and...
Clinical Data Presented at ESMO Shows ETAG(TM) System's Potential in Predicting Response to Cancer Treatment MOUNTAIN VIEW, Calif., Nov. 4...
Manuel Hidalgo, M.D., Ph.D., Joins ACLARA BioSciences Scientific Advisory Board Another Distinguished Oncologist Highlights Company's Advancements...
ViroLogic and ACLARA BioSciences Revise Merger Terms ViroLogic Provides Preliminary Third Quarter Revenue Estimate SOUTH SAN FRANCISCO, Calif. and...
ACLARA and GlaxoSmithKline Evaluating eTag(TM) Technology for Patient Selection for Targeted Cancer Therapies MOUNTAIN VIEW, Calif., Oct. 5...
ACLARA Data at EORTC-NCI-AACR Symposium Demonstrates ETAG(TM) System Potential in Cancer Drug Development and Treatment Prognosis MOUNTAIN VIEW...
ViroLogic and ACLARA Mail Definitive Proxy for Proposed Merger Date Set for Stockholder Meetings SOUTH SAN FRANCISCO, Calif. and MOUNTAIN VIEW...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지